Contact this trialFirst, we need to learn more about you.
GABA-T Inhibitor
Vigabatrin for Insulin Resistance
Recruiting1 awardPhase 2
Saint Louis, Missouri
This trial will study whether an existing drug used to treat seizures can also help treat nonalcoholic fatty liver disease, a common complication of obesity.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.